Related Experiment Videos
Chronic idiopathic urticaria treatment
J M Negro-Alvarez1, J C Miralles-López
1Allergy Section. "Virgen de la Arrixaca" University Hospital. Associated Professor of Allergy. University of Murcia. Murcia. Spain. jnegroa@meditex.es
Allergologia Et Immunopathologia
|October 25, 2001
Summary
Chronic idiopathic urticaria (CIU) is a prevalent skin condition. First-line treatment involves H1 antihistamines, with combinations offering further symptom relief for chronic urticaria patients.
Area of Science:
- Dermatology
- Allergology
- Pharmacology
Background:
- Chronic idiopathic urticaria (CIU) affects 0.1-3% of people in the USA and Europe.
- CIU accounts for approximately 75% of all chronic urticaria cases.
- Persistent urticarial wheals can affect up to 40% of patients for over 10 years.
Purpose of the Study:
- To outline therapeutic management strategies for chronic idiopathic urticaria.
- To detail first-line and combination antihistamine treatments for CIU symptom palliation.
Main Methods:
- Review of current therapeutic approaches for chronic idiopathic urticaria.
- Discussion of antihistamine classifications and combination therapies.
- Mention of adjunctive treatments like ephedrine spray for oropharyngeal edema.
Main Results:
- H1 antihistamines with low sedation potential are the primary first-line treatment for CIU.
- Various combinations of first and second-generation antihistamines can be effective.
- Specific combinations include doxepin and H2 anti-receptor antihistamines with H1 antihistamines.
Conclusions:
- Symptom palliation is the primary goal in CIU management.
- A stepwise approach using various antihistamine combinations is recommended.
- Emerging treatments like desloratadine and anti-leukotrienes show promise for some CIU patients.